Feb 23, 2023
1:30
For every 30 shares held, investors received 1. The price per share adjusted from $0.16 to $4.67.
The split itself did not change the total investment value.
Corbus Pharmaceuticals Holdings, Inc. (LSE:0SZI) operates in the Pharmaceuticals: major industry.
Corbus Pharmaceuticals Holdings, Inc. company overviewCorbus Pharmaceuticals Holdings, Inc.'s most recent stock split was on February 23, 2023. It was a 1-for-30 reverse split, so shareholders received 1 share for every 30 they held.
Corbus Pharmaceuticals Holdings, Inc. (LSE:0SZI) has split its stock 2 times: a 33333-for-1000000 reverse split on February 14, 2023 and a 1-for-30 reverse split on February 23, 2023.
Corbus Pharmaceuticals Holdings, Inc. has split its stock 2 times. This history records 2 reverse splits between February 14, 2023 and February 23, 2023.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Corbus Pharmaceuticals Holdings, Inc.'s 1-for-30 reverse split on February 23, 2023, every 30 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Corbus Pharmaceuticals Holdings, Inc. has not announced a new split in our records. Its most recent split was on February 23, 2023, 3 years ago. Companies announce splits in advance, and any new LSE:0SZI split will appear on this page.